help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2008-0146
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, B. S. J.
Right arrow Articles by Young, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, B. S. J.
Right arrow Articles by Young, S. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Molecular Endocrinology 22 (11): 2496-2504
Copyright © 2008 by The Endocrine Society

The Expression of GPIHBP1, an Endothelial Cell Binding Site for Lipoprotein Lipase and Chylomicrons, Is Induced by Peroxisome Proliferator-Activated Receptor-{gamma}

Brandon S. J. Davies, Hironori Waki, Anne P. Beigneux, Emily Farber, Michael M. Weinstein, Damien C. Wilpitz, Li-Jung Tai, Ronald M. Evans, Loren G. Fong, Peter Tontonoz and Stephen G. Young

Departments of Medicine (B.S.J.D., A.P.B., E.F., L.G.F., S.G.Y.), Pathology and Laboratory Medicine (H.W., D.C.W., P.T.), and Human Genetics (M.M.W., S.G.Y.), David Geffen School of Medicine, University of California, Los Angeles, California 90095; Howard Hughes Medical Institute (H.W., D.C.W., L.-J.T., R.M.E., P.T.) and Gene Expression Laboratory (L.-J.T., R.M.E.), Salk Institute for Biological Studies, La Jolla, California 92037; and Division of Endocrinology and Metabolism (L.-J.T.), Department of Medicine, University of California, San Diego, La Jolla, California 92093

Address all correspondence and requests for reprints to: Brandon S. J. Davies, 650 Charles E. Young Drive South, Los Angeles, California 90095. E-mail: bdavies{at}mednet.ucla.edu.

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), a protein in the lymphocyte antigen 6 (Ly-6) family, plays a key role in the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 binds lipoprotein lipase and chylomicrons and is expressed along the luminal surface of microvascular endothelial cells. Lipolysis is known to be regulated by metabolic factors and is controlled at multiple levels, including the number of LPL binding sites on capillaries. Here, we tested the possibility that GPIHBP1 expression could be regulated by dietary perturbations and by peroxisome proliferator-activated receptors (PPARs). Gpihbp1 transcript levels in the heart and in brown and white adipose tissue increased with fasting and returned toward baseline after refeeding. A PPAR{gamma} agonist increased Gpihbp1 expression in adipose tissue, heart, and skeletal muscle, whereas PPAR{alpha} and PPAR{delta} agonists had no effect. Gpihbp1 was expressed in endothelial cells of embryoid bodies generated from mouse embryonic stem cells, and Gpihbp1 expression in embryoid bodies was up-regulated by a PPAR{gamma} agonist. Sequences upstream from exon 1 of Gpihbp1 contain a strong PPAR binding site, and that site exhibited activity in a luciferase reporter assay. Gpihbp1 transcript levels in brown and white adipose tissue were lower in endothelial cell PPAR{gamma} knockout mice than in littermate control mice, suggesting that PPAR{gamma} regulates Gpihbp1 expression in vivo. We conclude that GPIHBP1 is regulated by dietary factors and by PPAR{gamma}.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARα  |  PPARγ  |  RXRα
Ligands:   Rosiglitazone



This article has been cited by other articles:


Home page
J. Lipid Res.Home page
W. K. Sonnenburg, D. Yu, E-C. Lee, W. Xiong, G. Gololobov, B. Key, J. Gay, N. Wilganowski, Y. Hu, S. Zhao, et al.
GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4
J. Lipid Res., December 1, 2009; 50(12): 2421 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Williams
Some Things Just Have to Be Done In Vivo: GPIHBP1, Caloric Delivery, and the Generation of Remnant Lipoproteins
Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 792 - 795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society